TRPV4 and activation of airway sensory nerves: The role of ATP

Sara Bonvini (London, United Kingdom), Sara Bonvini, Mark Birrell, Megan Grace, Sarah Maher, John Adcock, Michael Wortley, Eric Dubuis, Yee-Man Ching, Anthony Ford, Fisnik Shala, Montserrat Miralpiex, Gema Tarrason, Jaclyn Smith, Maria Belvisi

Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sara Bonvini (London, United Kingdom), Sara Bonvini, Mark Birrell, Megan Grace, Sarah Maher, John Adcock, Michael Wortley, Eric Dubuis, Yee-Man Ching, Anthony Ford, Fisnik Shala, Montserrat Miralpiex, Gema Tarrason, Jaclyn Smith, Maria Belvisi. TRPV4 and activation of airway sensory nerves: The role of ATP. Eur Respir J 2015; 46: Suppl. 59, 3252

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Central role for the TRPV4-ATP-P2X3 axis in sensory nerve activation and the late asthmatic response
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016

The TRPV4 ion channel plays a key role in allergic asthma
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016


Levosimendan reduces cholinergic bronchoconstriction: The role of KATP channels
Source: International Congress 2016 – Lung function and imaging: new findings and new approaches
Year: 2016

Transient receptor potential channels in a mouse model of isocyanate-induced airway hyperresponsiveness
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014

Activation of TRPV4 causes bronchoconstriction: A possible role in respiratory disease?
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013


Muscarinic M3 receptors on structural cells regulate neutrophilic inflammation in mice
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014

Combined loss of M2 and M3 muscarinic acetylcholine receptor (mAChR) function in mutant mice increases serotonin airway responsiveness (AR)
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014

Andrographolide restores steroid sensitivity to block LPS/IFN-γ-induced IL-27 and airway hyperresponsiveness in mice
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015


Anti-tussive effects of FAAH inhibition: The role of endocannabinoids and downstream signalling pathways in the inhibition of vagal sensory nerve activation
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015

Role of TRPV1 and TRPV2 gene polymorphisms in the development of airway hyperresponsiveness to osmotic stimuli in patients with asthma
Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma
Year: 2016


Characterization of an endogenous Th17-cell generation during sensitization in the murine lung
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015

Alpha-7 nicotinic receptor stimulation reduces airway inflammation in a murine model of asthma
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016

Airway reactivity and neuroimmune relationships in animal model of air born irritants induced symptoms – Role of trigeminal TRPA1 channels
Source: Annual Congress 2012 - Indoor and outdoor air pollution
Year: 2012

Investigating the role of prostaglandin D2 in airway sensory nerve firing: Relevance to disease
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013


Beneficial effects of menthol are mediated via a TRPM8-independent mechanism
Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD
Year: 2015

Validation of a hypertussive model of cough in the rabbit
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013


Allosteric inhibition of the cystic fibrosis transmembrane conductance regulator (CFTR) slows airway mucus transport in normal sheep
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015


The muscarinic M3 receptor regulates allergen-induced airway remodeling in mice
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013


The role of lL-17 in the OVA-LPS driven model of lung inflammation
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015

Characterisation of a steroid-insensitive severe asthma model
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014